Home - Products - Others - Other Targets - Brain Derived Acidic Fibroblast Growth Factor (1-11)

Brain Derived Acidic Fibroblast Growth Factor (1-11)

CAS No. 211362-82-2

Brain Derived Acidic Fibroblast Growth Factor (1-11)( ——— )

Catalog No. M41154 CAS No. 211362-82-2

FNLPLGNYKKP is a peptide fragment of brain-derived acidic fibroblast growth factor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Brain Derived Acidic Fibroblast Growth Factor (1-11)
  • Note
    Research use only, not for human use.
  • Brief Description
    FNLPLGNYKKP is a peptide fragment of brain-derived acidic fibroblast growth factor.
  • Description
    FNLPLGNYKKP is a peptide fragment of brain-derived acidic fibroblast growth factor.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    211362-82-2
  • Formula Weight
    1290.53
  • Molecular Formula
    C62H95N15O15
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Incensole acetate

    Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.

  • 1,2-Dimyristoyl-sn-g...

    1,2-dimyristoyl-sn-glycerol is able to increase AChE activity by 35-40% at concentrations of 25 micrograms/ml in the parasite S. mansoni..

  • Brandioside

    Brandioside shows strong antioxidant, and neuroprotective effects, it significantly attenuates glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 microM; it exhibits significant inhibition of advanced glycation end product formation with the IC50 value of 4.6-25.7 μM.